SCHEMBL85836

SCHEMBL85836

C=C(C)C(=O)OCCNC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.50
TSHR P16473 4/20 0.48
ALDH1A1 P00352 3/20 0.43
POLB P06746 1/20 0.41
APEX1 P27695 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13475292 0.91 THRB (0.59) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL1756100 0.87 TSHR (0.58) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL16309318 0.86 THRB (0.52) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL685408 0.86 THRB (0.52) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL12808628 0.86 THRB (0.52) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL2195083 0.86 THRB (0.52) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL8823545 0.85 THRB (0.47) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL1008804 0.84 THRB (0.50) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL14345594 0.84 THRB (0.50) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL194228 0.84 THRB (0.55) THRBTSHRALDH1A1POLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021148667-A1 AESTHETIC DENTAL FILLING MATERIAL HAVING HIGH CURING DEPTH IVOCLAR VIVADENT AG (LI) 2021-07-29 WO claimed
WO-2019034597-A1 FORCE-RESPONSIVE POLYMERSOMES AND NANOREACTORS; PROCESSES UTILIZING THE SAME ADOLPHE MERKLE INSTITUTE, UNIVERSITY OF FRIBOURG (CH) 2019-02-21 WO claimed
US-9464228-B2 Liquid crystal composition, method for manufacturing the same, and film FUJIFILM CORPORATION (JP) 2016-10-11 US claimed
US-20150344782-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL AND METHOD FOR MANUFACTURING THE SAME, AND FILM FUJIFILM CORPORATION (JP) 2015-12-03 US claimed
US-20150191652-A1 LIQUID CRYSTAL COMPOSITION, METHOD FOR MANUFACTURING THE SAME, AND FILM FUJIFILM CORPORATION (JP) 2015-07-09 US claimed
US-20150191651-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL AND METHOD FOR MANUFACTURING THE SAME, AND FILM FUJIFILM CORPORATION (JP) 2015-07-09 US claimed
US-8257837-B2 Organic light-emitting device SHOWA DENKO K.K. (JP) 2012-09-04 US claimed
US-5597661-A Solid polymer electrolyte, battery and solid-state electric double layer capacitor using the same as well as processes for the manufacture thereof SHOWA DENKO K.K. (JP) 1997-01-28 US claimed
EP-0051691-B1 ADDITION POLYMERIZABLE POLYETHERS HAVING ONE PENDANT ETHYLENICALLY UNSATURATED URETHANE GROUP THE DOW CHEMICAL COMPANY (US) 1986-10-29 EP claimed
US-20250352435-A1 AESTHETIC DENTAL FILLING MATERIAL HAVING HIGH CURING DEPTH IVOCLAR VIVADENT AG (LI) 2025-11-20 US disclosed
US-11732194-B2 Cholesteric liquid crystal layer, laminate, optically anisotropic body, reflective film, method for producing cholesteric liquid crystal layer, anti-counterfeit medium, and determination method FUJIFILM CORPORATION (JP) 2023-08-22 US disclosed
US-11693278-B2 Liquid crystal diffraction element and method for producing liquid crystal diffraction element FUJIFILM CORPORATION (JP) 2023-07-04 US disclosed
US-20230161211-A1 METHOD FOR PRODUCING CHOLESTERIC LIQUID CRYSTAL LAYER, CHOLESTERIC LIQUID CRYSTAL LAYER, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE LAYER FUJIFILM CORPORATION (JP) 2023-05-25 US disclosed
US-11634638-B2 Liquid crystal composition, reflective layer, method for producing reflective layer, and copolymer FUJIFILM CORPORATION (JP) 2023-04-25 US disclosed
US-4977055-A RESIN DISPESEDIN NONAQUEOUS SOLVENT FUJI PHOTO FILM CO., LTD. (JP) 1990-12-11 US disclosed
EP-0268617-A4 MOLD APPARATUS FOR USE IN SPIN CASTING A PRECISELY CONFIGURED ARTICLE. INTERNAT HYDRON CORP (US) 1989-08-22 EP disclosed
EP-0268617-A1 MOLD APPARATUS FOR USE IN SPIN CASTING A PRECISELY CONFIGURED ARTICLE ALLERGAN, INC (US) 1988-06-01 EP disclosed
WO-1987007208-A1 MOLD APPARATUS FOR USE IN SPIN CASTING A PRECISELY CONFIGURED ARTICLE INTERNATIONAL HYDRON CORPORATION (US) 1987-12-03 WO disclosed
US-4680149-A CONTACT LENS INTERNATIONAL HYDRON CORPORATION (US) 1987-07-14 US disclosed
EP-0051691-B1 ADDITION POLYMERIZABLE POLYETHERS HAVING ONE PENDANT ETHYLENICALLY UNSATURATED URETHANE GROUP THE DOW CHEMICAL COMPANY (US) 1986-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191651-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL AND METHOD FOR MANUFACTURING THE SAME, AND FILM PYM1, C9, LANCL2 THRB 4118/4885TSHR 4393/4885ALDH1A1 1441/4885
US-20250352435-A1 AESTHETIC DENTAL FILLING MATERIAL HAVING HIGH CURING DEPTH CAD, REV1, RAD51 THRB 4344/4885TSHR 4285/4885ALDH1A1 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.